Furthermore, although we showed that ERMN, MOBP, PLP1, and OPALIN might be novel biomarkers for GBM in older adults via the WGCNA and relative experiments, their molecular mechanisms in GBM in older adults should be determined with additional experiments. The gene discussed is ERMN; the disease is glioblastoma.